{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T12:08:53Z","timestamp":1789042133917,"version":"build-2803163510"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100005762","name":"National Taiwan University Hospital","doi-asserted-by":"publisher","award":["115-N0119"],"award-info":[{"award-number":["115-N0119"]}],"id":[{"id":"10.13039\/501100005762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["NSTC 114-2314-B-002\\u2013303"],"award-info":[{"award-number":["NSTC 114-2314-B-002\\u2013303"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejves.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Vascular and Endovascular Surgery"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ejvs.2026.06.013","type":"journal-article","created":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T23:59:18Z","timestamp":1781308758000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical Impact of Initial Low Molecular Weight Heparin Use in Hospitalised Patients with Venous Thromboembolism Treated with Direct Oral Anticoagulants: A Propensity Score Matched Study"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6743-1118","authenticated-orcid":false,"given":"Jung-Chi","family":"Hsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen-Yu","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5799-6513","authenticated-orcid":false,"given":"Donna","family":"Shu-Han Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng-Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huai-Wen","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3790-484X","authenticated-orcid":false,"given":"Jen-Kuang","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4 Suppl.","key":"10.1016\/j.ejvs.2026.06.013_bib1","doi-asserted-by":"crossref","first-page":"S495","DOI":"10.1016\/j.amepre.2009.12.017","article-title":"Venous thromboembolism: a public health concern","volume":"38","author":"Beckman","year":"2010","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ejvs.2026.06.013_bib2","doi-asserted-by":"crossref","DOI":"10.2196\/24346","article-title":"The costs and cardiovascular benefits in patients with peripheral artery disease from a fourth-generation synchronous telehealth program: retrospective cohort study","volume":"23","author":"Lee","year":"2021","journal-title":"J Med Internet Res"},{"key":"10.1016\/j.ejvs.2026.06.013_bib3","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.025438","article-title":"Long-term visit-to-visit glycemic variability as a predictor of major adverse limb and cardiovascular events in patients with diabetes","volume":"12","author":"Hsu","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2026.06.013_bib4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12933-023-02085-y","article-title":"Prediabetes increases the risk of major limb and cardiovascular events","volume":"22","author":"Hsu","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/j.ejvs.2026.06.013_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s11239-015-1319-y","article-title":"Guidance for the practical management of warfarin therapy in the treatment of venous thromboembolism","volume":"41","author":"Witt","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.ejvs.2026.06.013_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.chest.2015.11.026","article-title":"Antithrombotic therapy for VTE disease: CHEST guideline and expert panel report","volume":"149","author":"Kearon","year":"2016","journal-title":"Chest"},{"key":"10.1016\/j.ejvs.2026.06.013_bib7","first-page":"225","article-title":"Low-molecular-weight heparin (LMWH) in the treatment of thrombosis","volume":"9","author":"Holzheimer","year":"2004","journal-title":"Eur J Med Res"},{"key":"10.1016\/j.ejvs.2026.06.013_bib8","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1056\/NEJMoa0906598","article-title":"Dabigatran versus warfarin in the treatment of acute venous thromboembolism","volume":"361","author":"Schulman","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2026.06.013_bib9","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1056\/NEJMoa1306638","article-title":"Edoxaban versus warfarin for the treatment of symptomatic venous thromboembolism","volume":"369","author":"B\u00fcller","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2026.06.013_bib10","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1056\/NEJMoa1007903","article-title":"Oral rivaroxaban for symptomatic venous thromboembolism","volume":"363","author":"Bauersachs","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2026.06.013_bib11","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1056\/NEJMoa1207541","article-title":"Apixaban for extended treatment of venous thromboembolism","volume":"368","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2026.06.013_bib12","doi-asserted-by":"crossref","first-page":"22","DOI":"10.36401\/JQSH-23-16","article-title":"Improving venous thromboembolism prophylaxis through service integration, policy enhancement, and health informatics","volume":"7","author":"Abuzied","year":"2024","journal-title":"Glob J Qual Saf Healthc"},{"key":"10.1016\/j.ejvs.2026.06.013_bib13","doi-asserted-by":"crossref","first-page":"e59","DOI":"10.1055\/s-0040-1705137","article-title":"Modified IMPROVE VTE risk score and elevated D-dimer identify a high venous thromboembolism risk in acutely ill medical population for extended thromboprophylaxis","volume":"4","author":"Spyropoulos","year":"2020","journal-title":"TH Open"},{"key":"10.1016\/j.ejvs.2026.06.013_bib14","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1001\/jamainternmed.2019.2431","article-title":"Perioperative management of patients with atrial fibrillation receiving a direct oral anticoagulant","volume":"179","author":"Douketis","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejvs.2026.06.013_bib15","doi-asserted-by":"crossref","first-page":"2226","DOI":"10.1016\/j.jtha.2025.03.003","article-title":"Perioperative management of direct oral anticoagulants in patients having a high-bleed-risk surgery or neuraxial procedure: the perioperative anticoagulant use for surgery evaluation (PAUSE)-2 pilot randomized trial","volume":"23","author":"Douketis","year":"2025","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.ejvs.2026.06.013_bib16","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/CCM.0b013e31820a91b9","article-title":"Plasma levels of tumor necrosis factor-\u03b1 and interleukin-6 are associated with diastolic heart failure through downregulation of sarcoplasmic reticulum Ca2+ ATPase","volume":"39","author":"Wu","year":"2011","journal-title":"Crit Care Med"},{"key":"10.1016\/j.ejvs.2026.06.013_bib17","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1001\/jamainternmed.2015.3540","article-title":"Nationwide population science: lessons from the Taiwan National Health Insurance Research Database","volume":"175","author":"Hsing","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/j.ejvs.2026.06.013_bib18","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2018062","article-title":"Data resource profile: the National Health Insurance Research Database (NHIRD)","volume":"40","author":"Lin","year":"2018","journal-title":"Epidemiol Health"},{"key":"10.1016\/j.ejvs.2026.06.013_bib19","doi-asserted-by":"crossref","first-page":"349","DOI":"10.2147\/CLEP.S196293","article-title":"Taiwan\u2019s National Health Insurance Research Database: past and future","volume":"11","author":"Hsieh","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/j.ejvs.2026.06.013_bib20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1161\/CIRCULATIONAHA.113.004450","article-title":"Treatment of acute venous thromboembolism with dabigatran or warfarin and pooled analysis","volume":"129","author":"Schulman","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.ejvs.2026.06.013_bib21","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1056\/NEJMoa1302507","article-title":"Oral apixaban for the treatment of acute venous thromboembolism","volume":"369","author":"Agnelli","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2026.06.013_bib22","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1056\/NEJMoa1113572","article-title":"Oral rivaroxaban for the treatment of symptomatic pulmonary embolism","volume":"366","author":"B\u00fcller","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2026.06.013_bib23","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/j.chest.2021.07.056","article-title":"Executive summary: Antithrombotic therapy for VTE disease: second update of the CHEST guideline and expert panel report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.ejvs.2026.06.013_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1038\/s41397-024-00329-y","article-title":"Being precise with anticoagulation to reduce adverse drug reactions: are we there yet?","volume":"24","author":"Cross","year":"2024","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.ejvs.2026.06.013_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.phrs.2016.06.023","article-title":"Direct oral anticoagulants: current indications and unmet needs in the treatment of venous thromboembolism","volume":"118","author":"Bertoletti","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/j.ejvs.2026.06.013_bib26","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.017559","article-title":"Direct oral anticoagulant use: a practical guide to common clinical challenges","volume":"9","author":"Chen","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.ejvs.2026.06.013_bib27","doi-asserted-by":"crossref","first-page":"2914","DOI":"10.3390\/jcm14092914","article-title":"Challenges and opportunities of direct oral anticoagulant (DOAC) therapy in complex clinical scenarios: a comprehensive review and practical guide","volume":"14","author":"Miceli","year":"2025","journal-title":"J Clin Med"},{"key":"10.1016\/j.ejvs.2026.06.013_bib28","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.ejvs.2026.06.013_bib29","first-page":"165","article-title":"Use of anticoagulants in elderly patients: practical recommendations","volume":"4","author":"Robert-Ebadi","year":"2009","journal-title":"Clin Interv Aging"},{"key":"10.1016\/j.ejvs.2026.06.013_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.jceh.2025.102534","article-title":"Efficacy and safety of direct oral anticoagulants compared to vitamin K antagonists for atrial fibrillation in patients with liver cirrhosis: an update systematic review and meta-analysis","volume":"15","author":"Miranda","year":"2025","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/j.ejvs.2026.06.013_bib31","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.thromres.2020.11.036","article-title":"Using oral anticoagulants among chronic kidney disease patients to prevent recurrent venous thromboembolism: a systematic review and meta-analysis","volume":"198","author":"Alhousani","year":"2021","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2026.06.013_bib32","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.thromres.2018.02.144","article-title":"Direct oral anticoagulant (DOAC) versus low-molecular-weight heparin (LMWH) for treatment of cancer associated thrombosis (CAT): a systematic review and meta-analysis","volume":"173","author":"Li","year":"2019","journal-title":"Thromb Res"},{"key":"10.1016\/j.ejvs.2026.06.013_bib33","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1915103","article-title":"Apixaban for the treatment of venous thromboembolism associated with cancer","volume":"382","author":"Agnelli","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ejvs.2026.06.013_bib34","first-page":"97","article-title":"Referral, diagnosis, and pharmacological management of peripheral artery disease: perspectives from Taiwan","volume":"39","author":"Lee","year":"2023","journal-title":"Acta Cardiol Sin"}],"container-title":["European Journal of Vascular and Endovascular Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588426005745?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1078588426005745?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:18:22Z","timestamp":1789039102000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1078588426005745"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":34,"alternative-id":["S1078588426005745"],"URL":"https:\/\/doi.org\/10.1016\/j.ejvs.2026.06.013","relation":{},"ISSN":["1078-5884"],"issn-type":[{"value":"1078-5884","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical Impact of Initial Low Molecular Weight Heparin Use in Hospitalised Patients with Venous Thromboembolism Treated with Direct Oral Anticoagulants: A Propensity Score Matched Study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Vascular and Endovascular Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejvs.2026.06.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier B.V. on behalf of European Society for Vascular Surgery.","name":"copyright","label":"Copyright"}]}}